for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AmerisourceBergen Corp.

ABC.N

Latest Trade

88.31USD

Change

0.76(+0.87%)

Volume

297,559

Today's Range

87.20

 - 

88.69

52 Week Range

69.36

 - 

94.29

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
87.55
Open
87.57
Volume
297,559
3M AVG Volume
25.94
Today's High
88.69
Today's Low
87.20
52 Week High
94.29
52 Week Low
69.36
Shares Out (MIL)
206.76
Market Cap (MIL)
18,028.49
Forward P/E
11.64
Dividend (Yield %)
1.83

Next Event

AmerisourceBergen Corp at JPMorgan Healthcare Conference

Latest Developments

More

AmerisourceBergen Says May Be Unable To Recover Amounts Owed from Diplomat Pharmacy

AmerisourceBergen Reports Q4 Earnings Per Share $0.63

Ups Collaborates With AmerisourceBergen To Transport Medical Products Via Drone At Multiple U.S. Hospital Systems

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About AmerisourceBergen Corp.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.

Industry

Biotechnology & Drugs

Contact Info

1300 Morris Dr

+1.610.7277000

https://www.amerisourcebergen.com/abcnew/

Executive Leadership

Steven H. Collis

Chairman of the Board, President, Chief Executive Officer

James F. Cleary

Chief Financial Officer, Executive Vice President

Silvana Battaglia

Chief Human Resource Officer, Executive Vice President

Gina K. Clark

Executive Vice President, Chief Communications & Administration Officer

Dale Danilewitz

Executive Vice President, Chief Information Officer

Key Stats

2.58 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

153.1K

2018

167.9K

2019

179.6K

2020(E)

190.8K
EPS (USD)

2017

5.880

2018

6.490

2019

7.090

2020(E)

7.525
Price To Earnings (TTM)
22.77
Price To Sales (TTM)
0.10
Price To Book (MRQ)
6.29
Price To Cash Flow (TTM)
13.71
Total Debt To Equity (MRQ)
156.08
LT Debt To Equity (MRQ)
151.25
Return on Investment (TTM)
8.53
Return on Equity (TTM)
2.13

Latest News

Latest News

AmerisourceBergen to pay $625 million in U.S. civil fraud settlement

AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.

AmerisourceBergen in $625 mln drug distribution settlement, New York says

AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.

UPDATE 1-U.S. subpoenas AmerisourceBergen over opioid products

Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

U.S. subpoenas AmerisourceBergen over opioid products

Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

AmerisourceBergen sees Memphis plant back on track by 2019; shares rise

Drug distributor AmerisourceBergen Corp <ABC.N> posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent.

BRIEF-AmerisourceBergen Reports Q2 Earnings Per Share $1.29

* AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS

AmerisourceBergen quarterly profit falls 30 percent

Drug distributor AmerisourceBergen Corp on Wednesday posted a 30 percent fall in second-quarter profit hurt by high operating expenses.

BRIEF-Amerisourcebergen Production At Pharmedium's Memphis Outsourcing Facility Remains Voluntarily Suspended

* PRODUCTION AT PHARMEDIUM'S MEMPHIS OUTSOURCING FACILITY REMAINS VOLUNTARILY SUSPENDED

Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.

BRIEF-AmerisourceBergen Says Stockholders Rejected Proposal To Urge Board To Report On Governance Measures Implemented Related To Opioids

* AMERISOURCEBERGEN SAYS STOCKHOLDERS REJECTED PROPOSAL TO URGE BOARD TO REPORT ON GOVERNANCE MEASURES IMPLEMENTED RELATED TO OPIOIDS - SEC FILING Source text: (http://bit.ly/2HZhCXW) Further company coverage:

BRIEF-Deal talks between Walgreens and AmerisourceBergen have ended without an agreement- CNBC

* TALKS BETWEEN WALGREENS AND AMERISOURCEBERGEN ABOUT AN ACQUISITION OF THE WHOLESALE DRUG DISTRIBUTOR HAVE ENDED WITHOUT AN AGREEMENT - CNBC, CITING SOURCES Source text: http://cnb.cx/2HP99qj Further company coverage:

Amerisource deal may not keep Walgreens competitive: analysts

Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.

Walgreens bid for AmerisourceBergen would be a head-scratcher - analysts

Walgreens' potential move to buy a drug distributor in which it already has a 26 percent stake has some analysts questioning the logic and wondering if it would be enough to compete in an evolving U.S. healthcare sector.

Walgreens in talks to buy AmerisourceBergen: WSJ

The largest U.S. drugstore operator Walgreens Boots Alliance Inc has made a takeover approach to drug distributor AmerisourceBergen Corp, the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.

Walgreens in talks to buy AmerisourceBergen -WSJ

Walgreens Boots Alliance Inc has made a takeover approach for U.S. drug distributor AmerisourceBergen Corp, the Wall Street Journal reported on Monday.

BRIEF-Walgreens In Early-Stage Talks To Buy AmerisourceBergen- CNBC,Citing DJ

* WALGREENS IN EARLY-STAGE TALKS TO BUY AMERISOURCEBERGEN, OF WHICH IT ALREADY OWNS 26 PERCENT - CNBC,CITING DJ

AmerisourceBergen gets U.S. subpoena regarding Memphis plant

AmerisourceBergen Corp <ABC.N> on Tuesday said it received a grand jury subpoena from U.S. prosecutors seeking documents related to laboratory testing procedures at a facility that produces around half of the compounded drugs it supplies.

BRIEF-AmerisourceBergen Anticipates Operations At Memphis Facility Will Resume This Quarter

* AMERISOURCEBERGEN CORP CFO SAYS MEMPHIS FACILITY REMAINS CLOSED AND CURRENTLY ANTICIPATE OPERATIONS WILL RESUME THIS QUARTER - CONF CALL

BRIEF-Amerisourcebergen Reports Fiscal 2018 First Quarter Results

* AMERISOURCEBERGEN REPORTS FISCAL 2018 FIRST QUARTER RESULTS

AmerisourceBergen profit more than triples on tax benefit

U.S. drug distributor AmerisourceBergen Corp said on Tuesday its quarterly profit more than tripled, helped by a $587.6 million benefit due to changes to U.S. tax laws.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up